Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AXA Interim / Quarterly Report 2022

Nov 2, 2022

1135_iss_2022-11-02_024a75ce-6f79-42a9-8448-ae7d12ec6fe2.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Paris, November 2, 2022 (5:45pm CET)

9M22 Activity Indicators

Sustained high-quality revenue mix

  • Gross revenues1 up 2% to Euro 78.4 billion
    • P&C Commercial lines Insurance2 revenues up 6% to Euro 24.4 billion
    • P&C Personal lines revenues up 4% to Euro 13.3 billion
    • Health revenues up 14% to Euro 13.1 billion
  • Solvency II ratio3 at 225%, down 2 points vs. 1H22
  • Preliminary estimated claims from Hurricane Ian of Euro 0.4 billion, gross of tax and net of reinsurance

"AXA has delivered another strong performance in the first nine months of 2022 in a challenging environment," said Alban de Mailly Nesle, Chief Financial Officer of AXA. "Our revenue mix continued to be of high quality, focused on growing technical lines while reducing our exposure in Nat Cat Reinsurance and traditional G/A Savings."

"Health and P&C Commercial lines Insurance revenues have remained strong, increasing by 14% and 6%, respectively. In P&C Personal lines, the pricing environment is showing clear signs of improvement. Overall, we expect that the actions we have taken to counterbalance inflation impacts in P&C this year should keep our strong underlying technical profitability on track across the Group."

"This year has been marked by a series of natural catastrophes, notably Hurricane Ian, which is estimated to be one of the costliest hurricanes in the United States. We expect AXA XL's market share of claims from Hurricane Ian to be around 0.7%, well below its historical market share, reflecting underwriting actions already taken to cut Nat Cat exposure."

"Our robust balance sheet puts us in a strong position against the current macroeconomic backdrop, with the Solvency II ratio at 225% and a very high-quality asset mix benefiting from a prudent allocation over the years."

"We remain confident in our strategy, focused on developing in technical lines in our core markets, including through selective acquisitions such as recently in Spain."

"I would like to thank all our colleagues, agents and partners for their commitment and support in achieving these results, as well as our clients for their continued trust."

Key figures (in Euro billion, unless otherwise noted)
9M21 9M22 Change on a
reported basis
Change on a
comparable basis
Gross Revenues1 76.0 78.4 +3% +2%
o/w Property & Casualty 38.5 40.7 +6% +3%
o/w Health 11.5 13.1 +14% +14%
o/w Life & Savings 24.5 23.2 -5% -6%
o/w Asset Management4 1.1 1.2 +10% +2%
1H22 9M22 Change on a
reported basis
Solvency II ratio3
(%)
227% 225% -2 pts

GIE_AXA_Confidential

All notes are on page 7 of this document.

9M22key highlights

Revenues

Total revenues were up 2%1 driven by (i) Property & Casualty (+3%),with growth in Commercial lines Insurance2 revenues (+6%) from continued favorable price effects, partly offset by Nat Cat exposure reduction at AXA XL Reinsurance (-20%) while Personal lines revenues grew by +4% driven by improved pricing, notably in Europe, (ii) Health (+14%), with continued strong growth across all geographies, and (iii) Asset Management (+2%)4 , with higher transaction fees. This was partly offset by (iv) Life & Savings(-6%), as the growth in Protection was more than offset by lower revenues in Unit-Linked, notably from thenon-repeat of a large Group contract in France, and in G/A5 Savingsmostly in France, Italy and Japan.

Solvency

Solvency II ratio3 was 225% as of September 30, 2022, down 2 points versus June 30, 2022, resulting mainly from (i) an operating return net of accrued dividends (+1 point) which includes theimpact from elevated Nat Cats (-1 point), more than offset by (ii) negative financial market effects (-3 points) due to increased implied volatility and lower equity performance, partly compensated by higher interest rates.

Ratings

AM Best: On July 8, 2022, AM Best assigned a financial strength rating to AXA S.A. of 'A+ (Superior)', with a stable outlook, as well as a long-term issuer credit ratings of 'aa-(Superior)'.

Fitch: On May 16, 2022, Fitch Ratings reaffirmed the financial strength rating of AXA's core operating subsidiaries at 'AA-', maintaining a positive outlook and assigned AXA S.A. a financial strength rating at 'AA-'. Fitch Ratings also upgraded AXA S.A.'s long term issuer default ratings from'A' to 'A+'.

S&P: On March 28, 2022, S&P Global Ratings reaffirmed the financial strength rating of AXA core's operating subsidiaries at 'AA-', with a stable outlook. On May 11, 2022, S&P Global Ratings also assigned AXA S.A. a financial strength rating at 'A+' and upgraded AXA S.A.'s long term issuer credit ratings from'A' to 'A+'.

Moody's: On June 15, 2021, Moody's Investors Service reaffirmed the financial strength rating of AXA's core subsidiaries at 'Aa3', with a stable outlook. On July 1, 2022, Moody's Investors Service also assigned AXA S.A. a financial strength rating at 'Aa3' and upgraded AXA S.A.'s long-term senior debt rating from 'A2' to 'A1'.

Main transactions

Main transactions from July 1, 2022:

  • Completion of AXA S.A.'s transformation into the Group's internal reinsurer following receipt of its insurance license (May 10, 2022) and its merger on June 30, 2022, with its captive internal reinsurer AXA Global Re (announced July 1, 2022);
  • Announced sale of AXA Germany closed life and pensions portfolio of Euro 16 billion insurance reserves for Euro 660 million6 (July 14, 2022);
  • Completed execution on October 3, 2022, of AXA's Euro 1 billion share buy-back program announced on August 3, 2022;
  • Completed execution on September 26, 2022, of a cash tender offer on two series of AXA S.A. subordinated notes announced on August 29, 2022, for a total debt amount repurchased of USD 616 million;
  • Announced completion of sale of AXA's insurance operations7 in Malaysia for ca. Euro 0.1 billion (August 30, 2022);
  • Announced the successful placement of Euro 850million of senior notes due 2030 (October 6, 2022);
  • Announced that AXA has entered into exclusive negotiations to acquire Groupe Assurances du Crédit Mutuel España (October 18, 2022).

Property & Casualty

Total revenues were up 3% to Euro40.7 billion.

  • Commercial lines Insurancerevenues increased by 6% to Euro 24.4 billion driven by (i) Europe (+7%) and France (+8%), both from higher volumes and favorable price effects, (ii) AXA Assistance (+33%), primarily from strong volumes in Travel, and (iii) AXA XL Insurance (+1%), from favorable price effects, partly offset by lower exposure reflecting continued underwriting discipline.
  • AXA XL Reinsurance revenuesdecreased by 20% to Euro 2.9 billion as a result of a strong reduction in Nat Cat exposure, in line with our strategy. This was partly offset by favorable price effects.
  • Personal lines revenues were up 4% to Euro 13.3 billion, driven by both higher revenues in non-Motor (+4%), mainly from favorable price effects in particular in Europe, reflecting improved momentum in Belgium, UK & Ireland, and Spain, and Motor (+3%) across all geographies,mostly driven by improving pricing trends in Turkey and Europe.

Hurricane Ian made landfall in the United States on September 28, 2022, impacting the state of Florida and subsequently several Southeastern states of the United States. It is expected to be one of the costliest hurricanes to hit the United States in recent years. Management's preliminary estimate of claims from Hurricane Ian is ca. Euro 0.4 billion, grossof tax and net of reinsurance. This equates to a market share of around 0.7%8 based on a current estimated industry insured loss of ca. USD 60 billion8 .

Life & Savings

Total revenues were down by 6% to Euro 23.2 billion:

  • Protection revenues grew by 3% to Euro 11.7 billion, driven by Asia (+6%), mostly from higher sales of Protection with Unit-Linked products in Japan, and by Europe (+2%), mainly from higher volumes of semiautonomousGroup Lifeproducts in Switzerland.
  • Unit-Linkedrevenues were down 12% to Euro 4.8billion, driven by France (-12%), following the non-repeat of a large Group contract in 1H21 and by Asia (-50%), mostly in Hong Kong, from lower sales due to mobility restrictions.
  • G/A Savings revenues declined by 13% to Euro 6.5 billion, mainly driven by (i) France (-13%), due to lower sales of traditional G/A products as well as the non-repeat of a large Group contract in 3Q21, partly offset by the continued success of Eurocroissance, (ii) Europe (-12%), mostly in Italy, reflecting lower sales through the banking channel in a continued challenging market environment, and (iii) Asia (-25%), mostly in Japan, following elevated sales of a capital-light G/A 9 single premium whole-life product last year.

Net flows10 amounted to Euro +2.9 billion, driven by (i) Health10 (Euro +3.6 billion), with positive net flows across all geographies, (ii) Protection (Euro +3.0billion), mostly in Asia and France, and (iii) Unit-Linked (Euro +1.6 billion), mostly in France, partly offset by (iv) G/A Savings (Euro -5.2 billion), driven by strong outflows in traditional G/A (Euro -5.3 billion) across geographies, in line with our strategy.

New Business Value10,11 was stable at Euro 1.9 billion, and Annual Premium Equivalent (new business volume)10,11 was up 3% to Euro 4.6 billion, mostly driven by Switzerland,notably from higher sales of semi-autonomous Group Life products, and by France,reflecting the expansion of international business in Group Health. NBV margin10,11was down 1.4 points to 41.3%, notably driven by a higher share of Group business in Health.

Health

Total revenues were up 14% to Euro 13.1 billion, with growth across all geographies.

  • Group business was up 24% to Euro 6.6billion, mostly driven by strong growth in (i) France (+29%),from higher volumes in international business primarily through partnerships, (ii) Europe (+15%), driven by UK & Ireland from higher volumes and favorable price effects, and (iii) Mexico (+12%),primarily from favorable price effects.
  • Individual business was up 5% to Euro 6.4billion, mainly from (i) Europe (+4%) across all countries, notably in Germany from favorable price effects, (ii) International (+19%), mostly from positive price effects in Mexico and higher average premiums in Turkey, and (iii) France (+11%)from both higher volumes and positive price effects.

Asset Management

From January 1, 2022, the scope of the Asset Management segment also includes Architas.

Total Asset Management revenues increased by 2% to Euro 1.2 billion12 , driven by higher transaction fees, partly offset by lower performance and management fees.

Asset Management net inflows amounted to Euro +18billion, with continued strong inflows from third-party clients in both AXA IM Alts (Euro +5 billion) and AXA IM Core (Euro +5billion), as well as from Asian JVs (Euro +8 billion).

Average assets under management13 amounted to Euro 760 billion, down -4%, with strong net inflows more than offset by unfavorable market effects in the last nine-month period.

Definitions

France: includes insurance activities, banking activities and holdings in France.

Europe: includes Switzerland (insurance activities), Germany (insurance activities and holdings), Belgium (insurance activities and holdings), United Kingdom and Ireland (insurance activities and holdings), Spain (insurance activities) and Italy (insurance activities).

AXA XL: includes insurance and reinsurance activities and holdings.

Asia: includes insurance activities in Japan (including the P&C business which was previously reported under "Asia-Direct") and holdings, Hong Kong, Asia High Potentials of which (i) Thailand P&C, Indonesia L&S (excluding the bancassurance entity) and China P&C are fully consolidated, and (ii) China L&S, Thailand L&S, the Philippines L&S and Indonesian L&S bancassurance businesses are consolidated under the equity method and contribute only to the underlying earnings14 and net income, and South Korea -Direct, and Asia Holdings.

International: consists of (i) AXA Mediterranean Holdings, (ii) EME-LATAM, which includes Mexico (insurance activities), Colombia (insurance activities), Turkey (insurance activities and holdings), the Gulf Region (insurance activities until June 2021 as disposed on September 7, 2021), AXA Bank Belgium (banking activities until December 2021 as disposed on December 31, 2021), Luxembourg (insurance activities and holdings), Brazil (insurance activities and holdings) and Greece (insurance activities until March 2021 as disposed on May 31, 2021) which are fully consolidated, as well as Russia (Reso) (insurance activities) which is consolidated under the equity method and contribute only to the underlying earnings and net income, and (iii) Africa & Asia, which includes Singapore (holdings, insurance activities until December 2021 as disposed on February 11, 2022), Morocco (insurance activities and holdings), Nigeria (insurance activities and holdings) and Malaysia P&C (insurance activities until June 2022 as disposed on August 30, 2022) which are fully consolidated, as well as India (P&C insurance activities until June 2021 as disposed on September 8, 2021, L&S insurance activities and holdings) which is consolidated under the equity method and contribute only to the underlying earnings and net income.

Transversal & Central Holdings: includes AXA Investment Managers, AXA Assistance, AXA Liabilities Managers, AXA Life Europe, Architas (previously reported under "France"), AXA S.A. (including AXA S.A. Reinsurance, previously reported under "AXA Global Re") and other Central Holdings.

GIE_AXA_Confidential

Exchange rates

For 1 Euro End of Period Exchange rate Average Exchange rate
FY21 9M22 9M21 9M22
USD 1.14 0.98 1.20 1.06
CHF 1.04 0.96 1.09 1.01
GBP 0.84 0.88 0.86 0.85
JPY 1.31 1.42 1.30 1.36
HKD 8.87 7.69 9.29 8.33

Notes

1 Change in gross revenues is on a comparable basis (constant forex, scope and methodology).

2 Commercial lines Insurance refers to P&C Commercial lines excluding AXA XL Reinsurance.

3 The Solvency II ratio is estimated primarily using AXA's internal model calibrated based on an adver se 1/200 year shock. It includes a theoretical amount for dividends accrued for the first nine months of 2022, based on the full year dividend of Euro 1.54 per share paid in 2022 for FY21. Dividends are proposed by the Board, at its discretion based on a variety of factors described in AXA's 2021 Universal Registration Document, and then submitted to AXA's shareholders for approval. This estimate should not be considered in any way to be an indication of the actual divid end amount, if any, for 2022 financial year. For further information on AXA's internal model and Solvency II disclosures, please refer to AXA Group's SFCR as of December 31, 2021, available on AXA's website (www.axa.com).

4 Since January 1, 2022, the scope of the Asset management segment also includes Architas.

5 General Account.

by AXA's statutory auditors.

6 Consideration subject to potential contractual adjustments. The transaction is subject to customary closing conditions, including the receipt of regulatory approvals, and is expected to close in Q4 2023.

7 Operations in Malaysia related to AXA XL and AXA Partners were not within the scope of this transaction.

8 Based on estimated insured market loss relating to Hurricane Ian of around USD 60 billion which is within the current broad range of estimates. The estimates of other companies may differ. Market share based on gross of tax and net of reinsurance basis.

9 Capital light products are G/A Savings products which, at inception, create more Eligible Own Funds than the economic capital they consume.

10 Life & Savings net flows, APE, NBV and NBV margin include Health "life-like" business.

11 Annual premium equivalent (APE), NBV, and NBV margin are non-GAAP financial measures. APE, NBV, and NBV margin and other non-GAAP financial measures are defined in the Glossary set forth set forth on pages 57 to 64 of AXA's Half-Year 2022 Financial Report.

12 Includes the contribution from Architas (Euro 87 million).

13 Includes the contribution from Architas. Excludes the contribution from Asian joint ventures, which are consolidated under the equity method.

14 Underlying earnings is a non-GAAP financial measure, or alternative performance measure ("APM"). A reconciliation from APM underlying earnings to the most directly reconcilable line item, subtotal or total in the financial statements of the corresponding period is provided on page 16 of AXA's Half-Year 2022 Financial Report. The above mentioned and other non-GAAP financial measures used in this press release are defined in the Glossary set forth on pages 57 to 64 of AXA's Half-Year 2022 Financial Report.

All comments and changes are on a comparable basis for activity indicators (constant forex, scope and methodology). Most significant changes in scope are as mentioned below:

  • (i) The change in gross revenues, APE and NBV on comparable basis excludes the contribution from Greece, the Gulf region, and Singapore for the first nine months of 2021.
  • (ii) The change in gross revenues on comparable basis excludes the contribution from AXA Bank Belgium and Malaysia for the first nine months of 2021.

(iii) Since January 1, 2022, Architas is reported under "Asset Management" segment (previously reported under "Life & Savings" segment).

Actuarial and financial assumptions are not updated on a quarterly basis in NBV calculation. Actuarial and other financial as sumptions will be updated at year-end 2022.

Please note that financial figures and information in this press release have not been audited and they have not been subject to a limited review

ABOUT THE AXA GROUP

ABOUT THE AXA GROUP

The AXA Group is a worldwide leader in insurance and asset management, with 149,000 employees serving 95 million clients in 50 countries. In 2021, IFRS revenues amounted to Euro 99.9 billion and underlying earnings to Euro 6.8 billion. AXA had Euro 1,051 billion in assets under management, including assets managed on behalf of third parties, as of December 31, 2021.

The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA's American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.

The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.

It is a founding member of the UN Environment Programme's Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.

This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers' General Regulation are available on the AXA Group website (axa.com).

THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com

FOR MORE INFORMATION:

Investor Relations: +33.1.40.75.48.42

[email protected] [email protected] [email protected] [email protected] [email protected] [email protected] [email protected]

Individual Shareholder Relations: +33.1.40.75.48.43

Media Relations: +33.1.40.75.46.74

[email protected] [email protected] [email protected]

Corporate Responsibility strategy: axa.com/en/about-us/strategy-commitments

SRI ratings:

axa.com/en/investor/sri-ratings-ethical-indexes

IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS AND THE USE OF NON-GAAP FINANCIAL MEASURES

Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause AXA's actual results to differ materially from those expressed or implied in such forward looking statements. Please refer to Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2021 (the "2021 Universal Registration Document") and "Operating Highlights – Risk Factors" on page 8 of AXA's Half-Year Financial Report as of June 30, 2022 (the "Half-Year 2022 Financial Report") for a description of certain important factors, risks and uncertainties that may affect AXA's business and/or results of operations. AXA undertakes no obligation to publicly update or revise any of these forwardlooking statements, whether to reflect new information, future events or circumstances or otherwise, except as required by ap plicable laws and regulations.

In addition, this press release refers to certain non-GAAP financial measures, or alternative performance measures ("APMs"), used by Management in analyzing AXA's operating trends, financial performance and financial position and providing investors with additional information that Management believes to be useful and relevant regarding AXA's results. These non-GAAP financial measures generally have no standardized meaning and therefore may not be comparable to similarly labelled measures used by other companies. As a result, none of these non -GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS. Underlying earnings is an APM as defined in ESMA's guidelines and the AMF's related position statement issued in 2015. A reconciliation from the APM underlying earnings to the most directly reconcilable line item, subtotal or total in the financial statements of the corresp onding period is provided on page 16 of AXA's Half-Year 2022 Financial Report. The above mentioned and other non-GAAP financial measures used in this press release are defined in the Glossary set forth on pages 57 to 64 of AXA's Half-Year 2022 Financial Report.

APPENDIX 1: REVENUES BY GEOGRAPHY AND BY BUSINESS LINE

Gross revenues Totali o/w
Property & Casualty
o/w
Health
o/w
Life & Savings
o/w
Asset Management
in Euro million 9M21 9M22 Change on a
reported basis
Change on a
comparable basis
9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
France 21,084 21,786 +3% +2% 6,194 +6% 5,162 +27% 10,185 -9% - -
Europe 25,471 26,275 +3% +1% 14,377 +3% 4,876 +6% 7,022 -5% - -
Switzerland 4,526 4,992 +10% +3% 3,429 +2% 6
4
+26% 1,499 +6% - -
Germany 8,764 8,941 +2% +2% 3,778 +4% 2,801 +5% 2,362 -3% - -
Belgium 2,584 2,706 +5% +4% 1,759 +4% 115 +9% 832 +1% - -
UK & Ireland 4,140 4,431 +7% +5% 2,835 +3% 1,596 +9% - - - -
Spain 1,996 1,985 -1% -1% 1,240 +2% 210 +5% 535 -7% - -
Italy 3,460 3,220 -7% -7% 1,336 +5% 9
0
+10% 1,794 -15% - -
AXA XL 14,349 15,116 +5% -4% 14,988 -4% - - 128 -15% - -
Insurance 10,443 12,070 +16% +1% 12,070 +1% - - - - - -
Reinsurance 3,773 2,918 -23% -20% 2,918 -20% - - - - - -
Asia 8,345 8,605 +3% +1% 1,668 +4% 1,765 +4% 5,172 -1% - -
Japan 4,267 4,146 -3% +2% 325 +2% 1,046 +1% 2,774 +2% - -
Hong Kong 2,932 3,200 +9% -2% 229 +7% 605 +11% 2,366 -6% - -
Asia High Potentials 656 766 +17% +7% 619 +8% 114 +1% 3
2
+1% - -
South Korea - Direct 489 494 +1% 0
%
494 0
%
- - - - - -
International 4,350 3,826 -12% +24% 2,246 +31% 1,083 +16% 497 +9% - -
o/w EME-LATAM 3,277 3,101 -5% +27% 1,786 +38% 1,006 +17% 308 +1% - -
o/w Africa & Asia 1,074 725 -32% +10% 459 +7% 7
7
+2% 188 +24% - -
Transversal 2,369 2,758 +16% +12% 1,233 +27% 165 +7% 174 -1% 1,185 +2%
Total 75,969 78,365 +3% +2% 40,706 +3% 13,052 +14% 23,178 -6% 1,185 +2%

GIE_AXA_Confidential

i Including Banking (Euro 245 million in 9M22 and Euro 401 million in 9M21).

APPENDIX 2: PROPERTY & CASUALTY – REVENUE CONTRIBUTION & GROWTH BY BUSINESS LINE

Personal Commercial
in Euro million Personal
Motor
Change Personal
Non-Motor
Change Total
Personal
Change Commercial
Motor
Change Commercial
Non-Motor
Change Total
Commercial
Change 9M22 Change
France 1,575 +3% 1,593 +3% 3,168 +3% 672 +9% 2,354 +8% 3,026 +8% 6,194 +6%
Europe 4,947 0% 3,114 +2% 8,061 +1% 1,133 +2% 5,183 +8% 6,316 +7% 14,377 +3%
Switzerland 1,118 -2% 600 +1% 1,718 -1% 111 0
%
1,600 +5% 1,711 +5% 3,429 +2%
Germany 957 -2% 1,205 +4% 2,162 +1% 133 +1% 1,483 +8% 1,616 +7% 3,778 +4%
Belgium 483 -1% 416 +6% 899 +2% 217 +4% 642 +8% 859 +7% 1,759 +4%
UK & Ireland 1,098 +5% 395 -9% 1,492 +1% 457 0
%
886 +10% 1,343 +6% 2,835 +3%
Spain 622 -3% 250 +2% 872 -1% 4
9
+11% 319 +9% 368 +9% 1,240 +2%
Italy 669 +3% 248 +2% 917 +3% 166 +4% 253 +12% 419 +8% 1,336 +5%
AXA XL - - - - - - 235 -5% 14,753 -4% 14,988 -4% 14,988 -4%
Insurance - - - - - - 235 -5% 11,834 +1% 12,070 +1% 12,070 +1%
Reinsurance - - - - - - - - 2,918 -20% 2,918 -20% 2,918 -20%
Asia 1,093 +1% 271 +15% 1,363 +3% 110 0% 195 +17% 305 +10% 1,668 +4%
Japan 309 +3% 1
7
-1% 325 +2% - - - - - - 325 +2%
Hong Kong 3
5
+2% 6
2
+9% 9
7
+6% 1
9
+39% 114 +4% 133 +8% 229 +7%
Asia High Potentials 371 +1% 7
7
+46% 447 +7% 9
1
-5% 8
1
+41% 172 +12% 619 +8%
South Korea - Direct 378 -1% 115 +7% 494 0
%
- - - - - - 494 0
%
International 558 +42% 199 +51% 757 +44% 386 +37% 1,103 +21% 1,489 +25% 2,246 +31%
o/w EME-LATAM 367 +67% 181 +55% 548 +63% 354 +40% 884 +24% 1,238 +29% 1,786 +38%
o/w Africa & Asia 190 +3% 1
8
+21% 208 +4% 3
2
+5% 219 +9% 251 +8% 459 +7%
Transversal - - - - - - 417 +15% 742 +45% 1,160 +33% 1,233 +27%
Total 8,172 +3% 5,177 +4% 13,348 +4% 2,954 +9% 24,330 +2% 27,284 +3% 40,706 +3%
o/w Commercial lines Insurance 2,954 +9% 21,411 +6% 24,366 +6% 24,366 +6%

Personal lines net new contracts (NNC) amounted to +601k, driven by(i)International (+316k) mainly coming from strong sales in Motor in Turkey as a result of higher market share, (ii) Europe (+222k), mostly reflecting strong new business sales in Motor through a partnership in Italy, and (iii) France (+68k) following successful commercial actions.

Property & Casualty: Price effect by country and business line
9M22 (in %) Personal lines Commercial linesi
France +0.5% +4.8%
Europe +2.5% +3.0%
Switzerland -0.4% +0.4%
Germany +3.8% +3.6%
Belgium +4.4% +4.3%
UK & Ireland +3.1% +3.7%
Spain +3.8% +5.6%
Italy +1.0% +2.8%
AXA XLii +6.3%
Insurance - +6.6%
Reinsurance - +5.1%
Asia -0.8% -0.4%
Japan +0.3% -
Hong Kong +0.1% -2.0%
Asia High Potentials -5.7% +0.9%
South Korea - Direct +2.0% -
International +27.1% +12.1%
Transversal - 0.0%
Total +2.9% +5.4%

i. Renewals only, price effect calculated as a percentage of total gross written premiums in the prior year.

ii. Price increases on renewals at +7.9% in Insurance and +7.6% in Reinsurance. Price increase on renewals calculated as a percentage of renewed premiums.

Gross revenues Totali o/w
Protection
o/w
G/A Savings
o/w
Unit-Linked
in Euro million 9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
9M22 Change on a
comparable basis
France 10,185 -9% 3,475 -1% 3,404 -13% 3,305 -12%
Europe 7,022 -5% 3,413 +2% 2,274 -12% 1,125 -7%
Asia 5,172 -1% 4,450 +6% 559 -25% 163 -50%
AXA XL 128 -15% 68 -17% 60 -13% - -
International 497 +9% 259 +5% 208 +12% 28 +18%
Transversal 174 -1% - - - - 174 -1%
Total 23,178 -6% 11,665 +3% 6,505 -13% 4,796 -12%

GIE_AXA_Confidential

i Including Funds & Other (Euro 212 million).

APE 9M22 by product Total APE NBV NBV margin
in Euro million Protection Change i G/A Savings Changei Unit-Linked Changei Healthi
i
Changei MF & other i
Change
9M21 9M22 Changei 9M21 9M22 Changei 9M21 9M22 Changei
France 263 -25% 327 -22% 374 -5% 968 +34% - - 1,783 1,931 +2% 520 464 -14% 29% 24% -4 pts
Europe 784 +32% 197 -10% 161 -23% 95 -2% 17 -18% 1,096 1,254 +10% 515 592 +11% 47% 47% +1 pt
Switzerland 664 +43% 0 -35% 0 -98% 1 -6% - - 434 665 +42% 196 295 +39% 45% 44% -1 pt
Germany 5
0
-7% 9
6
-6% 2
6
+44% 9
4
-2% 1
1
-15% 284 278 -2% 171 167 -2% 60% 60% 0 pt
Belgium 1
8
-2% 1
8
-7% 8 +71% - - - - 3
8
4
3
+4% 2
8
3
0
+5% 75% 68% +1 pt
Spain 3
2
+8% 6 -9% 3
0
-26% - - 5 -22% 8
4
7
4
-12% 4
3
3
6
-16% 51% 49% -2 pts
Italy 2
0
-13% 7
6
-15% 9
7
-32% - - - - 257 193 -25% 7
7
6
4
-16% 30% 33% +3 pts
Asia 786 -4% 315 +4% 18 -53% 182 +2% - - 1,287 1,300 -3% 818 817 +1% 64% 63% +2 pts
Japan 383 +7% 1
5
-54% - - 9
1
+7% - - 498 489 +3% 600 619 +8% 121% 127% +6 pts
Hong Kong 237 -16% 3 -57% 1
2
-59% 4
3
+27% - - 315 295 -16% 116 110 -14% 37% 37% +1 pt
Asia High Potentials 166 -11% 297 +14% 6 -34% 4
7
-19% - - 474 516 0
%
102 8
8
-23% 22% 17% -5 pts
International 61 +8% 6 +75% 11 +57% - - - - 117 78 +19% 42 14 +27% 36% 18% +1 pt
o/w EME-LATAM 2
2
-17% 2 -21% 8 +97% - - - - 3
4
3
2
+5% 7 8 +10% 21% 24% +1 pt
o/w Africa & Asia 3
9
+30% 4 +317% 3 -20% - - - - 8
3
4
6
+34% 3
5
7 +59% 42% 14% +2 pts
Total 1,894 +4% 844 -11% 564 -12% 1,244 +25% 1
7
-20% 4,283 4,563 +3% 1,896 1,887 0
%
44% 41% -1 pt

GIE_AXA_Confidential

i Changes are at comparable basis (constant forex, scope and methodology). ii Only includes "life-like" Health business.

APPENDIX 6: LIFE & SAVINGS – NET FLOWS

Net flowsi
by country/region
in Euro billion 9M21 9M22
France +2.1 +1.1
Europe -0.3 -1.1
AXA XL -0.2 -0.2
Asia +2.6 +2.9
International +0.2 +0.1
Transversal 0.0 0.0
Total Life & Savings net flows +4.5 +2.9
Net flowsi by business line
in Euro billion 9M21 9M22
Protection +2.9 +3.0
Health +2.4 +3.6
G/A Savings -2.7 -5.2
i
i
o/w capital light
+1.4 +0.1
o/w traditional G/A -4.1 -5.3
Unit-Linked +1.9 +1.6
Mutual Funds & Other 0.0 0.0
Total Life & Savings net flows +4.5 +2.9

GIE_AXA_Confidential

i Life & Savings net flows include Health "life-like" business.

ii G/A Savings products which, at inception, create more EOF than the economic capital they consume.

APPENDIX 7: ASSETS UNDER MANAGEMENT ROLLFORWARD

APPENDIX 7:
ASSETS UNDER MANAGEMENT ROLLFORWARD
Assets under Management rollforward
in Euro billion Asset Management AXA IM AXA IM - Fully
consolidated scope
AXA IM - Asian Joint
Ventures
Architas Intra-segment
elimination
AUM as of December 31, 2021 910 887 779 108 32 -
9
Net flows 18 17 9 8 1
Market appreciation -101 -97 -93 -
4
-
6
2
Scope & other -
1
-
1
-
1
0 0
Forex impact 12 12 9 2 0
AUM as of September 30, 2022 838 817 703 114 28 -
8
Average AUM over the periodi,ii 760 738 30 -
9
Change of average AUM on a reported basis vs. 9M 2021 -3% -3%
Change of average AUM on a comparable basis vs. 9M 2021 -4% -4%

GIE_AXA_Confidential

i Average AUM for AXA IM is calculated excluding the contribution from Asian joint ventures. ii Includes the contribution from Architas.

Changes in scope:

APPENDIX 8: OTHER

Main press releases issued in 3Q22

Please refer to the following web site address for further details: https://www.axa.com/en/newsroom/press-releases

GIE_AXA_Confidential

Post 9M22 press releases

3Q22 and post 9M22 Operations on AXA shareholders' equity and debt:

Shareholders' equity: no significant operation

Debt:

Next main investor events

  • ‒ 23/02/2023 Full Year 2022 Earnings Release
  • ‒ 09/05/2023 –Q1 2023 Activity Indicators